• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SMITH & NEPHEW, INC. OXINIUM FEM HD 12/14 32MM +4; PROSTHESIS, HIP, SEMI-CONSTRAIN, MET/CERAM/POLY, CEMENT OR NON-PORO, UNCEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SMITH & NEPHEW, INC. OXINIUM FEM HD 12/14 32MM +4; PROSTHESIS, HIP, SEMI-CONSTRAIN, MET/CERAM/POLY, CEMENT OR NON-PORO, UNCEM Back to Search Results
Model Number 71343204
Medical Device Problem Code Loosening of Implant Not Related to Bone-Ingrowth (4002)
Health Effect - Clinical Codes Joint Dislocation (2374); Inadequate Osseointegration (2646)
Date of Event 11/22/2022
Type of Reportable Event Serious Injury
Event or Problem Description
It was reported that, after a thr surgery was performed on (b)(6) 2019, the patient experienced a dislocation due to loosening of the implant.A revision surgery was performed on (b)(6) 2022 were an oxinium fem hd 12/14 32mm +4 and a r3 20 deg xlpe acet lnr 32mm x 50mm were explanted.The current health status of the patient is unknown.All available information has been disclosed.If additional information should become available, a supplemental report will be submitted accordingly.
 
Additional Manufacturer Narrative
Smith & nephew is submitting this report pursuant to the provisions of 21 c.F.R.Part 803.This report may be based upon information which smith & nephew has not been able to investigate or verify prior to the required reporting date.This report does not reflect a conclusion by fda, smith & nephew, or its employees, that the report constitutes an admission that the device, smith & nephew or its employees caused or contributed to the potential event described in this report.(b)(4).
 
Additional Manufacturer Narrative
H3, h6: the device was not returned for evaluation; therefore, a device analysis could not be performed.The clinical/medical investigation concluded that, per case communication it was reported, ¿the surgeon does not blame implant.¿ as of the date of this medical investigation, the requested clinical documentation (including the operative report) has not been provided; therefore, there were no clinical factors found which would have definitively contributed to the event.The patient impact beyond the reported implant loosening, dislocation and revision/explantation cannot be determined.The patient¿s current health status remains unknown.Therefore, no further clinical/medical assessment can be rendered.Should additional information/documentation become available, the clinical/medical task may be re-opened for further evaluation.A review of the production order did not reveal a manufacturing abnormality that could have caused or contributed to the reported incident.A review of complaint history revealed similar events for the listed device over the previous 12 months, but no similar events for the batch based on the historical data, this failure mode will be monitored for future complaints for any necessary corrective actions.A review of the instructions for use documents for total hip systems revealed that loosening has been identified in warnings and precautions, that may result from muscle looseness and/or malpositioning of components.It also states that periodic x-rays, prescribed by the physician, are recommended for comparison to immediate postoperative conditions to detect long-term evidence of loosening.A review of the risk management file revealed this failure mode was previously identified.The anticipated risk level is still adequate.A historical review concluded that there are no prior actions related to this product and event.At this time, we have no reason to suspect that the product failed to meet any product specifications at the time of manufacture.With the results of this investigation the root cause of this event could not be determined.Factors that could contribute to the reported event include abnormal motion over time, bone degeneration, size selected, inadequate integration between the cement and bone/implant, osteolysis and/or traumatic injury.Based on this investigation, the need for corrective action is not indicated.Should the device or additional information be received, the complaint will be reopened.No further investigation is warranted for this complaint; however, we will continue to monitor for future complaints and investigate as necessary.We consider this investigation closed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OXINIUM FEM HD 12/14 32MM +4
Common Device Name
PROSTHESIS, HIP, SEMI-CONSTRAIN, MET/CERAM/POLY, CEMENT OR NON-PORO, UNCEM
Manufacturer (Section D)
SMITH & NEPHEW, INC.
1450 brooks rd.
memphis TN 38116
Manufacturer (Section G)
SMITH & NEPHEW, INC.
1450 brooks rd.
memphis TN 38116
Manufacturer Contact
holly topping
7000 west william cannon drive
austin, TX 78735
5123913905
MDR Report Key16009611
Report Number1020279-2022-04972
Device Sequence Number14830579
Product Code LZO
UDI-Device Identifier03596010474223
UDI-Public03596010474223
Combination Product (Y/N)N
Initial Reporter CountryAS
PMA/510(K) Number
K021673
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2019
Device Explanted Year2022
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Other,Foreign,Health Professional,User Facility
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 01/13/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Model Number71343204
Device Catalogue Number71343204
Device Lot Number18HM00687
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 11/22/2022
Supplement Date Received by Manufacturer01/10/2023
Initial Report FDA Received Date12/19/2022
Supplement Report FDA Received Date01/13/2023
Date Device Manufactured08/01/2018
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
71337650/R3 20 DEG XLPE ACET LNR 32MM X 50MM
Outcome Attributed to Adverse Event Other;
Patient SexUnknown
-
-